Infection is a leading cause of death in patients with multiple myeloma. It occurs most often during the first 2 months after diagnosis. The spectrum of infections has changed: Streptococcus pneumoniae is no longer the most common organism isolated, and gram-negative infections are seen more often. Immunoprophylaxis with monthly intravenous immune globulin (IVIG) may reduce the risk of serious and recurrent infections.
|Number of pages||10|
|Journal||Infections in Medicine|
|State||Published - 1995|
- immune globulin, intravenous (IVIG)